Suppr超能文献

MrgX2是一种在背根神经节中表达的高效力促皮质素释放因子受体。

MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion.

作者信息

Robas Nicola, Mead Emma, Fidock Mark

机构信息

Department of Target Genomics, Pfizer Global Research and Development, Sandwich, Kent, CT13 N9J, United Kingdom.

出版信息

J Biol Chem. 2003 Nov 7;278(45):44400-4. doi: 10.1074/jbc.M302456200. Epub 2003 Aug 12.

Abstract

MrgX2 is a recently identified orphan G-protein-coupled receptor whose ligand and physiological function were unknown. Here we describe cortistatin, a neuropeptide for which no specific receptor has been identified previously, as a high potency ligand at MrgX2. Cortistatin has several biological functions including roles in sleep regulation, locomotor activity, and cortical function. Using a "reverse pharmacology" approach, we have identified a number of additional cyclic peptide agonists for MrgX2, determined their rank order of potency, and demonstrated that this receptor has a pharmacological profile distinct from the other characterized members of the Mrg (Mas-related genes) family. In MrgX2-expressing cells, cortistatin-stimulated increases in intracellular Ca2+ but had no effect on basal or forskolin-stimulated cAMP levels, suggesting that this receptor is Gq-coupled. Immunohistochemical and quantitative PCR studies show MrgX2 to have a limited expression profile, both peripheral and within the central nervous system, with highest levels in dorsal root ganglion.

摘要

MrgX2是一种最近发现的孤儿G蛋白偶联受体,其配体和生理功能尚不清楚。在此,我们描述了促皮质素,一种此前未鉴定出特异性受体的神经肽,它是MrgX2的高效配体。促皮质素具有多种生物学功能,包括在睡眠调节、运动活动和皮质功能方面发挥作用。通过“反向药理学”方法,我们鉴定出了多种MrgX2的环肽激动剂,确定了它们的效价顺序,并证明该受体具有与Mrg(Mas相关基因)家族其他已鉴定成员不同的药理学特征。在表达MrgX2的细胞中,促皮质素刺激细胞内Ca2+增加,但对基础或福斯可林刺激的cAMP水平没有影响,这表明该受体与Gq偶联。免疫组织化学和定量PCR研究表明,MrgX2在外周和中枢神经系统中的表达谱有限,在背根神经节中水平最高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验